Biomedical engineering

Max Hodak: What Really Kills Deep Tech Startups?

Max Hodak: What Really Kills Deep Tech Startups?

Max Hodak, CEO of Science, reveals that deep tech startup success, exemplified by their retinal implant, is fundamentally driven by robust internal infrastructure. He argues that meticulous design of processes like purchasing, hiring, and unique 'EigenReviews' dictate a company's iterative speed. Hodak emphasizes the irreplaceable founder's judgment, action-driven information generation, and the critical role of custom operating systems, including AI-native tools, in achieving impactful outcomes in complex, capital-intensive fields like biotech.

Builders Unscripted: Ep. 5 - Derya Unutmaz

Builders Unscripted: Ep. 5 - Derya Unutmaz

Derya Unutmaz, an immunologist, shares how AI, particularly Codex, is transforming biological research, from building custom cell analysis tools and T-cell simulators to envisioning a future of digital twins and personalized medicine, highlighting a coming "Science 2.0" paradigm.